(Q34303041)

1 August 2017

1 reference

title

Genetic markers in thyroid neoplasia (English)

1 reference

1 August 2017

Puxeddu E

1

1 reference

PubMed ID

11444172

1 August 2017

Fagin JA

series ordinal

2

1 reference

1 August 2017

1 June 2001

1 reference

Endocrinology and Metabolism Clinics of North America

1 August 2017

1 reference

1 August 2017

30

1 reference

1 August 2017

2

1 reference

1 August 2017

493-513, x

1 reference

Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

An allelotype of papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Glial Cell Line-Derived Neurotrophic Factor Differentially Stimulates Ret Mutants Associated with the Multiple Endocrine Neoplasia Type 2 Syndromes and Hirschsprung's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Progress in genetic screening of multiple endocrine neoplasia type 2A: is calcitonin testing obsolete?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Familial Papillary Thyroid Cancer--Many Syndromes, Too Many Genes?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

RET proto-oncogene in the development of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Predisposition to neoplastic transformation caused by gene replacement of H-ras1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

RET Mutation Screening in Familial Cutaneous Lichen Amyloidosis and in Skin Amyloidosis Associated With Multiple Endocrine Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Genetic alterations in thyroid tumor progression: association with p53 gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Influence of cellular DNA content on survival in differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Ras oncogene mutations in benign and malignant thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Familial papillary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The practical management of multiple endocrine neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The demise of follicular carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Familial occurrence of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Persephin, a novel neurotrophic factor related to GDNF and neurturin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Preferential induction of RET/PTC1 rearrangement by X-ray irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

H-ras protooncogene mutations in human thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Familial occurrence of differentiated, nonmedullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

RET proto-oncogene mutations in thyroid carcinomas: clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Association of multiple endocrine neoplasia type 2 and Hirschsprung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Molecular mechanisms of RET activation in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

RET proto-oncogene mutations in French MEN 2A and FMTC families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

The association of pheochromocytoma with carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Familial papillary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Serum thyroglobulin measurement. Utility in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Characterization of a multicomponent receptor for GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Functional receptor for GDNF encoded by the c-ret proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC: s

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970196-1

7 January 2021

10.1016/S0889-8529(05)70196-1

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11444172